Pre-order Enquiry
Request Free Sample
Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2021-2026
SKU ID : LPI-18615620 | Publishing Date : 24-Jun-2021 | No. of pages : 107
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2021-2026
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Osteoarthritis Pain Market Size 2016-2026
2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Drugs for Osteoarthritis Pain Segment by Type
2.2.1 Oral
2.2.2 Oral
2.2.3 External
2.3 Drugs for Osteoarthritis Pain Market Size by Type
2.3.1 Global Drugs for Osteoarthritis Pain Market Size CAGR by Type
2.3.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2016-2021)
2.4 Drugs for Osteoarthritis Pain Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Drugs for Osteoarthritis Pain Market Size by Application
2.5.1 Global Drugs for Osteoarthritis Pain Market Size CAGR by Application
2.5.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2016-2021)
3 Drugs for Osteoarthritis Pain Market Size by Players
3.1 Drugs for Osteoarthritis Pain Market Size Market Share by Players
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Players (2019-2021E)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2019-2021E)
3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs for Osteoarthritis Pain by Regions
4.1 Drugs for Osteoarthritis Pain Market Size by Regions (2016-2021)
4.2 Americas Drugs for Osteoarthritis Pain Market Size Growth (2016-2021)
4.3 APAC Drugs for Osteoarthritis Pain Market Size Growth (2016-2021)
4.4 Europe Drugs for Osteoarthritis Pain Market Size Growth (2016-2021)
4.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth (2016-2021)
5 Americas
5.1 Americas Drugs for Osteoarthritis Pain Market Size by Country (2016-2021)
5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Osteoarthritis Pain Market Size by Region (2016-2021)
6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain by Country (2016-2021)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Region (2016-2021)
8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2016-2021)
8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Drugs for Osteoarthritis Pain Market Forecast
10.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2021-2026)
10.1.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2021-2026)
10.1.2 Americas Drugs for Osteoarthritis Pain Forecast
10.1.3 APAC Drugs for Osteoarthritis Pain Forecast
10.1.4 Europe Drugs for Osteoarthritis Pain Forecast
10.1.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast
10.2 Americas Drugs for Osteoarthritis Pain Forecast by Countries (2021-2026)
10.2.1 United States Drugs for Osteoarthritis Pain Market Forecast
10.2.2 Canada Drugs for Osteoarthritis Pain Market Forecast
10.2.3 Mexico Drugs for Osteoarthritis Pain Market Forecast
10.2.4 Brazil Drugs for Osteoarthritis Pain Market Forecast
10.3 APAC Drugs for Osteoarthritis Pain Forecast by Region (2021-2026)
10.3.1 China Drugs for Osteoarthritis Pain Market Forecast
10.3.2 Japan Drugs for Osteoarthritis Pain Market Forecast
10.3.3 Korea Drugs for Osteoarthritis Pain Market Forecast
10.3.4 Southeast Asia Drugs for Osteoarthritis Pain Market Forecast
10.3.5 India Drugs for Osteoarthritis Pain Market Forecast
10.3.6 Australia Drugs for Osteoarthritis Pain Market Forecast
10.4 Europe Drugs for Osteoarthritis Pain Forecast by Country (2021-2026)
10.4.1 Germany Drugs for Osteoarthritis Pain Market Forecast
10.4.2 France Drugs for Osteoarthritis Pain Market Forecast
10.4.3 UK Drugs for Osteoarthritis Pain Market Forecast
10.4.4 Italy Drugs for Osteoarthritis Pain Market Forecast
10.4.5 Russia Drugs for Osteoarthritis Pain Market Forecast
10.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast by Region (2021-2026)
10.5.1 Egypt Drugs for Osteoarthritis Pain Market Forecast
10.5.2 South Africa Drugs for Osteoarthritis Pain Market Forecast
10.5.3 Israel Drugs for Osteoarthritis Pain Market Forecast
10.5.4 Turkey Drugs for Osteoarthritis Pain Market Forecast
10.5.5 GCC Countries Drugs for Osteoarthritis Pain Market Forecast
10.6 Global Drugs for Osteoarthritis Pain Forecast by Type (2021-2026)
10.7 Global Drugs for Osteoarthritis Pain Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Drugs for Osteoarthritis Pain Product Offered
11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Drugs for Osteoarthritis Pain Product Offered
11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Drugs for Osteoarthritis Pain Product Offered
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Drugs for Osteoarthritis Pain Product Offered
11.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Drugs for Osteoarthritis Pain Product Offered
11.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Horizon Pharma Main Business Overview
11.8.5 Horizon Pharma Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Drugs for Osteoarthritis Pain Product Offered
11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drugs for Osteoarthritis Pain Product Offered
11.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11. Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Daiichi Sankyo Main Business Overview
11.11.5 Daiichi Sankyo Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Drugs for Osteoarthritis Pain Product Offered
11.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Almatica Pharma Main Business Overview
11.13.5 Almatica Pharma Latest Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Astellas Pharma Main Business Overview
11.14.5 Astellas Pharma Latest Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Tide Pharmaceutical Main Business Overview
11.15.5 Tide Pharmaceutical Latest Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Iroko Pharmaceuticals Main Business Overview
11.16.5 Iroko Pharmaceuticals Latest Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Hengrui Pharmaceutical Main Business Overview
11.17.5 Hengrui Pharmaceutical Latest Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Abiogen Pharma Main Business Overview
11.18.5 Abiogen Pharma Latest Developments
12 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2021-2026
List of TablesTable 1. Drugs for Osteoarthritis Pain Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External
Table 5. Drugs for Osteoarthritis Pain Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2016-2021)
Table 8. Drugs for Osteoarthritis Pain Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2016-2021)
Table 11. Global Drugs for Osteoarthritis Pain Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2019-2021E)
Table 13. Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
Table 14. Drugs for Osteoarthritis Pain Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Osteoarthritis Pain Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Drugs for Osteoarthritis Pain Market Size Market Share by Regions 2016-2021
Table 19. Americas Drugs for Osteoarthritis Pain Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Country (2016-2021)
Table 21. Americas Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type (2016-2021)
Table 23. Americas Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application (2016-2021)
Table 25. APAC Drugs for Osteoarthritis Pain Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region (2016-2021)
Table 27. APAC Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type (2016-2021)
Table 29. APAC Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application (2016-2021)
Table 31. Europe Drugs for Osteoarthritis Pain Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country (2016-2021)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type (2016-2021)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Drugs for Osteoarthritis Pain
Table 44. Key Application and Potential Industries of Drugs for Osteoarthritis Pain
Table 45. Key Challenges of Drugs for Osteoarthritis Pain
Table 46. Key Trends of Drugs for Osteoarthritis Pain
Table 47. Global Drugs for Osteoarthritis Pain Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Drugs for Osteoarthritis Pain Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Drugs for Osteoarthritis Pain Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Application (2021-2026)
Table 53. Pfizer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 54. Pfizer Drugs for Osteoarthritis Pain Product Offered
Table 55. Pfizer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Johnson & Johnson Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 59. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Johnson & Johnson Latest Developments
Table 63. GlaxoSmithKline Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 64. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
Table 65. GlaxoSmithKline Main Business
Table 66. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. GlaxoSmithKline Latest Developments
Table 68. Bayer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 69. Bayer Drugs for Osteoarthritis Pain Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Bayer Latest Developments
Table 73. Eli Lilly Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 74. Eli Lilly Drugs for Osteoarthritis Pain Product Offered
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Eli Lilly Latest Developments
Table 78. Novartis Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 79. Novartis Drugs for Osteoarthritis Pain Product Offered
Table 80. Novartis Main Business
Table 81. Novartis Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Novartis Latest Developments
Table 83. Sanofi Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 84. Sanofi Drugs for Osteoarthritis Pain Product Offered
Table 85. Sanofi Main Business
Table 86. Sanofi Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Sanofi Latest Developments
Table 88. Horizon Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 89. Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
Table 90. Horizon Pharma Main Business
Table 91. Horizon Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Horizon Pharma Latest Developments
Table 93. Abbott Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 94. Abbott Drugs for Osteoarthritis Pain Product Offered
Table 95. Abbott Main Business
Table 96. Abbott Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Abbott Latest Developments
Table 98. Mylan Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 99. Mylan Drugs for Osteoarthritis Pain Product Offered
Table 100. Mylan Main Business
Table 101. Mylan Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Mylan Latest Developments
Table 103. Daiichi Sankyo Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 104. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
Table 105. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Daiichi Sankyo Main Business
Table 107. Daiichi Sankyo Latest Developments
Table 108. TEVA Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 109. TEVA Drugs for Osteoarthritis Pain Product Offered
Table 110. TEVA Main Business
Table 111. TEVA Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. TEVA Latest Developments
Table 113. Almatica Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 114. Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
Table 115. Almatica Pharma Main Business
Table 116. Almatica Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Almatica Pharma Latest Developments
Table 118. Astellas Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 119. Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
Table 120. Astellas Pharma Main Business
Table 121. Astellas Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Astellas Pharma Latest Developments
Table 123. Tide Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 124. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 125. Tide Pharmaceutical Main Business
Table 126. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 127. Tide Pharmaceutical Latest Developments
Table 128. Iroko Pharmaceuticals Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 129. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
Table 130. Iroko Pharmaceuticals Main Business
Table 131. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 132. Iroko Pharmaceuticals Latest Developments
Table 133. Hengrui Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 134. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 135. Hengrui Pharmaceutical Main Business
Table 136. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 137. Hengrui Pharmaceutical Latest Developments
Table 138. Abiogen Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 139. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
Table 140. Abiogen Pharma Main Business
Table 141. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 142. Abiogen Pharma Latest Developments
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2020
Figure 7. Drugs for Osteoarthritis Pain in Medical Care
Figure 8. Global Drugs for Osteoarthritis Pain Market: Medical Care (2016-2021) & ($ Millions)
Figure 9. Drugs for Osteoarthritis Pain in Personal Care
Figure 10. Global Drugs for Osteoarthritis Pain Market: Personal Care (2016-2021) & ($ Millions)
Figure 11. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2020
Figure 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player in 2020
Figure 13. Global Drugs for Osteoarthritis Pain Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Drugs for Osteoarthritis Pain Market Size 2016-2021 ($ Millions)
Figure 15. APAC Drugs for Osteoarthritis Pain Market Size 2016-2021 ($ Millions)
Figure 16. Europe Drugs for Osteoarthritis Pain Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2016-2021 ($ Millions)
Figure 18. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Country in 2020
Figure 19. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2020
Figure 20. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2020
Figure 21. United States Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Regions in 2020
Figure 25. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2020
Figure 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2020
Figure 27. China Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country in 2020
Figure 34. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2020
Figure 35. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2020
Figure 36. Germany Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2020
Figure 44. Egypt Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Drugs for Osteoarthritis Pain Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 50. APAC Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 51. Europe Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 53. United States Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 54. Canada Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 57. China Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 58. Japan Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 59. Korea Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 61. India Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 62. Australia Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 63. Germany Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 64. France Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 65. UK Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 66. Italy Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 67. Russia Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 68. Spain Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 71. Israel Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Drugs for Osteoarthritis Pain Market Size 2021-2026 ($ Millions)
